1. Home
  2. VATE vs QNCX Comparison

VATE vs QNCX Comparison

Compare VATE & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • QNCX
  • Stock Information
  • Founded
  • VATE 1994
  • QNCX 2012
  • Country
  • VATE United States
  • QNCX United States
  • Employees
  • VATE N/A
  • QNCX N/A
  • Industry
  • VATE Metal Fabrications
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VATE Industrials
  • QNCX Health Care
  • Exchange
  • VATE Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • VATE 82.6M
  • QNCX 92.3M
  • IPO Year
  • VATE 1996
  • QNCX 2019
  • Fundamental
  • Price
  • VATE $5.66
  • QNCX $1.95
  • Analyst Decision
  • VATE
  • QNCX Strong Buy
  • Analyst Count
  • VATE 0
  • QNCX 3
  • Target Price
  • VATE N/A
  • QNCX $9.67
  • AVG Volume (30 Days)
  • VATE 49.0K
  • QNCX 286.7K
  • Earning Date
  • VATE 11-06-2024
  • QNCX 11-13-2024
  • Dividend Yield
  • VATE N/A
  • QNCX N/A
  • EPS Growth
  • VATE N/A
  • QNCX N/A
  • EPS
  • VATE N/A
  • QNCX N/A
  • Revenue
  • VATE $1,231,500,000.00
  • QNCX N/A
  • Revenue This Year
  • VATE N/A
  • QNCX N/A
  • Revenue Next Year
  • VATE N/A
  • QNCX N/A
  • P/E Ratio
  • VATE N/A
  • QNCX N/A
  • Revenue Growth
  • VATE N/A
  • QNCX N/A
  • 52 Week Low
  • VATE $3.25
  • QNCX $0.51
  • 52 Week High
  • VATE $13.00
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • VATE 51.57
  • QNCX 52.02
  • Support Level
  • VATE $5.43
  • QNCX $1.80
  • Resistance Level
  • VATE $6.48
  • QNCX $2.09
  • Average True Range (ATR)
  • VATE 0.43
  • QNCX 0.21
  • MACD
  • VATE -0.05
  • QNCX -0.05
  • Stochastic Oscillator
  • VATE 22.94
  • QNCX 27.01

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: